Showing results (251-260 of 295) with videos related to

Sort By:
Pageof 30
ERJ Open Research|December 24, 2025
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtypeIfan Jenkin, Konstantinos Dimopoulos, Steven D Nathan, et al.
Chest|August 5, 2021
Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel ReportScott M Stevens, Scott C Woller, Lisa Baumann Kreuziger, et al.
Plos One|November 23, 2020
Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failureChristopher S King, Dhwani Sahjwani, A Whitney Brown, et al.
Chest|August 5, 2021
Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel ReportScott M Stevens, Scott C Woller, Lisa Baumann Kreuziger, et al.
Chest|February 17, 2022
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi StudyFranck F Rahaghi, Nicholas A Kolaitis, Ayodeji Adegunsoye, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 16, 2021
Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort studyMoon Kyoo Jang, Ilker Tunc, Gerald J Berry, et al.
The New England Journal of Medicine|May 20, 2014
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosisTalmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, et al.
The European Respiratory Journal|May 29, 2024
Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study resultsSteven D Nathan, Rahul Argula, Maria G Trivieri, et al.
BMJ Open Respiratory Research|February 3, 2016
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trialsLisa Lancaster, Carlo Albera, Williamson Z Bradford, et al.
The European Respiratory Journal|December 10, 2015
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W Noble, Carlo Albera, Williamson Z Bradford, et al.
Pageof 30